Untangling dopamine-adenosine receptor assembly in experimental parkinsonism

Abstract Parkinson’s disease (PD) is a dopaminergic-related pathology in which basal ganglia functioning are altered. It has been postulated that a direct receptor-receptor – i.e. dopamine D2 receptor (D2R) and adenosine A2A receptor (A2AR) – interaction may be finely regulating this brain area. Acc...

Full description

Saved in:
Bibliographic Details
Published inDisease models & mechanisms
Main Authors Fernández-Dueñas, Víctor, Taura, Jaume J., Cottet, Martin, Gómez-Soler, Maricel, López-Cano, Marc, Ledent, Catherine, Watanabe, Masahiko, Trinquet, Eric, Pin, Jean-Philippe, Luján, Rafael, Durroux, Thierry, Ciruela, Francisco
Format Journal Article
LanguageEnglish
Published 01.01.2014
Online AccessGet full text

Cover

Abstract Abstract Parkinson’s disease (PD) is a dopaminergic-related pathology in which basal ganglia functioning are altered. It has been postulated that a direct receptor-receptor – i.e. dopamine D2 receptor (D2R) and adenosine A2A receptor (A2AR) – interaction may be finely regulating this brain area. Accordingly, elucidating whether the pathology prompts changes on these structures could grant valuable information for the design of new PD therapies. Here, we first resolved a long-standing question concerning D2R-A2AR assembly in native tissue. Thus, by means of different complementary experimental approaches (i.e. immunoelectron microscopy, proximity ligation assay and TR-FRET), we unambiguously identified native D2R/A2AR oligomers in rat striatum. Subsequently, we determined that under pathological conditions (i.e. in a rat PD model) D2R-A2AR interaction was impaired. Collectively, these results provide definitive evidence for a native D2R/A2AR oligomer alteration in experimental parkinsonism, thus conferring the rationale for appropriate oligomer-based PD treatments.
AbstractList Abstract Parkinson’s disease (PD) is a dopaminergic-related pathology in which basal ganglia functioning are altered. It has been postulated that a direct receptor-receptor – i.e. dopamine D2 receptor (D2R) and adenosine A2A receptor (A2AR) – interaction may be finely regulating this brain area. Accordingly, elucidating whether the pathology prompts changes on these structures could grant valuable information for the design of new PD therapies. Here, we first resolved a long-standing question concerning D2R-A2AR assembly in native tissue. Thus, by means of different complementary experimental approaches (i.e. immunoelectron microscopy, proximity ligation assay and TR-FRET), we unambiguously identified native D2R/A2AR oligomers in rat striatum. Subsequently, we determined that under pathological conditions (i.e. in a rat PD model) D2R-A2AR interaction was impaired. Collectively, these results provide definitive evidence for a native D2R/A2AR oligomer alteration in experimental parkinsonism, thus conferring the rationale for appropriate oligomer-based PD treatments.
Author Trinquet, Eric
Durroux, Thierry
López-Cano, Marc
Gómez-Soler, Maricel
Ciruela, Francisco
Luján, Rafael
Taura, Jaume J.
Pin, Jean-Philippe
Watanabe, Masahiko
Cottet, Martin
Ledent, Catherine
Fernández-Dueñas, Víctor
Author_xml – sequence: 1
  givenname: Víctor
  surname: Fernández-Dueñas
  fullname: Fernández-Dueñas, Víctor
  organization: Universitat de Barcelona, Barcelona, Spain
– sequence: 2
  givenname: Jaume J.
  surname: Taura
  fullname: Taura, Jaume J.
  organization: Universitat de Barcelona, Barcelona, Spain
– sequence: 3
  givenname: Martin
  surname: Cottet
  fullname: Cottet, Martin
  organization: INSERM-CNRS, Montpellier, France
– sequence: 4
  givenname: Maricel
  surname: Gómez-Soler
  fullname: Gómez-Soler, Maricel
  organization: Universitat de Barcelona, Barcelona, Spain
– sequence: 5
  givenname: Marc
  surname: López-Cano
  fullname: López-Cano, Marc
  organization: Universitat de Barcelona, Barcelona, Spain
– sequence: 6
  givenname: Catherine
  surname: Ledent
  fullname: Ledent, Catherine
  organization: Université Libre de Bruxelles, Brussels, Belgium
– sequence: 7
  givenname: Masahiko
  surname: Watanabe
  fullname: Watanabe, Masahiko
  organization: Hokkaido University School of Medicine, Sapporo, Japan
– sequence: 8
  givenname: Eric
  surname: Trinquet
  fullname: Trinquet, Eric
  organization: Cisbio Bioessays, Codolet, France
– sequence: 9
  givenname: Jean-Philippe
  surname: Pin
  fullname: Pin, Jean-Philippe
  organization: INSERM-CNRS, Montpellier, France
– sequence: 10
  givenname: Rafael
  surname: Luján
  fullname: Luján, Rafael
  organization: UCLM, Albacete, Spain
– sequence: 11
  givenname: Thierry
  surname: Durroux
  fullname: Durroux, Thierry
  organization: INSERM-CNRS, Montpellier, France
– sequence: 12
  givenname: Francisco
  surname: Ciruela
  fullname: Ciruela, Francisco
  organization: Universitat de Barcelona, Barcelona, Spain
BookMark eNo9kEFPAyEUhImpiW314i_gbLKVB7TA0TRqTTbxYs8bFl4bdIEN9GD_vWtqPM1cZjLzLcgs5YSE3ANbAZf80ce4YqBBiisyB7WWjZYAs3_PxA1Z1PrJ2IZrYeak3aeTTcchpCP1ebQxJGysx5Tr5GhBh-MpF2prxdgPZxoSxe8RS4g4JQc62vIVUs0p1HhLrg92qHj3p0uyf3n-2O6a9v31bfvUNg6UFo1H3wvLXc-t1D0K55QyhsHBA3ql0GghBRitLCDzQhtpQa4V11pNL8xGLMnDpdeVXGvBQzdOe2w5d8C6Xw7dxKG7cBA_aftTdQ
CitedBy_id crossref_primary_10_1007_s12035_017_0696_y
crossref_primary_10_1007_s12035_018_1456_3
crossref_primary_10_3389_fphar_2018_01200
crossref_primary_10_3390_ijms22041719
crossref_primary_10_1111_ejn_13912
crossref_primary_10_1038_s41598_018_28682_6
crossref_primary_10_3389_fnins_2018_00604
crossref_primary_10_1007_s12035_018_1120_y
crossref_primary_10_1038_s41598_017_02037_z
crossref_primary_10_4103_1673_5374_226388
crossref_primary_10_1089_caff_2019_0008
crossref_primary_10_1007_s11302_021_09765_y
crossref_primary_10_3389_fphar_2017_00700
crossref_primary_10_3390_ijms22073467
crossref_primary_10_1016_j_neuropharm_2015_04_001
crossref_primary_10_3389_fphar_2020_00194
crossref_primary_10_1002_0471143030_cb1717s67
crossref_primary_10_3389_fnins_2022_1082375
crossref_primary_10_1038_s41598_017_10147_x
crossref_primary_10_1111_gbb_12432
crossref_primary_10_1242_dmm_027706
crossref_primary_10_3389_fendo_2022_931573
crossref_primary_10_1016_j_neubiorev_2018_09_026
crossref_primary_10_1146_annurev_pharmtox_011613_135952
crossref_primary_10_1016_j_neuropharm_2018_12_003
crossref_primary_10_1021_acs_jmedchem_7b01627
crossref_primary_10_1515_revneuro_2017_0087
crossref_primary_10_3389_fphar_2024_1390187
crossref_primary_10_1002_cpz1_794
crossref_primary_10_1042_BST20150276
crossref_primary_10_1111_febs_13577
crossref_primary_10_1124_mol_115_099440
crossref_primary_10_1016_j_neuropharm_2018_11_009
crossref_primary_10_3389_fnins_2017_00658
crossref_primary_10_1016_j_ejphar_2015_09_028
crossref_primary_10_1002_jbio_202100172
Cites_doi 10.1016/S0165-0173(97)00049-0
10.1212/01.WNL.0000095205.33940.99
10.1096/fj.09-141044
10.1038/41771
10.1093/ilar.38.1.41
10.2174/187152711797247803
10.1042/BST20120237
10.1517/13543780903241615
10.1074/jbc.M306451200
10.1021/ac049295f
10.1038/nchembio.396
10.1016/j.tibtech.2010.05.002
10.1073/pnas.90.19.8861
10.1016/S0301-0082(96)00040-8
10.1111/j.1755-5949.2009.00126.x
10.1097/00001756-200105080-00046
10.1016/j.parkreldis.2004.02.014
10.1126/science.2147780
10.1016/j.neuron.2011.10.038
10.1016/j.parkreldis.2004.02.015
10.1124/jpet.108.149617
10.1016/j.bbamem.2010.12.017
10.1016/S0166-2236(97)01096-5
10.1016/S0306-4522(02)00058-1
10.1038/nmeth.1213
10.1016/j.neuropharm.2013.10.036
10.1212/WNL.0b013e31821ccce4
10.2144/000113719
10.1016/j.pharmthera.2004.10.007
10.1177/1087057110384611
10.1016/B978-012547638-6/50019-5
10.1016/S0006-291X(03)00991-4
10.1111/j.1471-4159.2009.06078.x
10.1111/j.1471-4159.2012.07956.x
10.1016/j.expneurol.2013.12.021
ContentType Journal Article
DBID AAYXX
CITATION
DOI 10.1242/dmm.018143
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1754-8411
ExternalDocumentID 10_1242_dmm_018143
GroupedDBID 0R~
29G
2WC
53G
5GY
5VS
6~0
6~1
7X7
8FI
8FJ
AAFWJ
AAYXX
ABUWG
ADBBV
AENEX
AFKRA
AFPKN
AGGIJ
AIPOO
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BTFSW
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBS
EE-
F5P
F9R
FRJ
FRP
FYUFA
GROUPED_DOAJ
H13
HCIFZ
HMCUK
HYE
HZ~
INIJC
IPNFZ
KQ8
M7P
M~E
O9-
OK1
P2P
PIMPY
RHF
RHI
RIG
RNS
RPM
TR2
UKHRP
W2D
W8F
ID FETCH-LOGICAL-c1783-dedb3a2cb2a48be3cc779901fd1ed77e983431987a1e0d3894a14572887754963
ISSN 1754-8403
IngestDate Fri Aug 23 00:36:18 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c1783-dedb3a2cb2a48be3cc779901fd1ed77e983431987a1e0d3894a14572887754963
OpenAccessLink https://doi.org/10.1242/dmm.018143
ParticipantIDs crossref_primary_10_1242_dmm_018143
PublicationCentury 2000
PublicationDate 2014-01-01
PublicationDateYYYYMMDD 2014-01-01
PublicationDate_xml – month: 01
  year: 2014
  text: 2014-01-01
  day: 01
PublicationDecade 2010
PublicationTitle Disease models & mechanisms
PublicationYear 2014
References Gerfen (2021042501165322700_b15-0080057) 1990; 250
Pinna (2021042501165322700_b25-0080057) 2009; 18
Kern (2021042501165322700_b18-0080057) 2012; 73
Schwarting (2021042501165322700_b29-0080057) 1996; 50
Ferré (2021042501165322700_b10-0080057) 1997; 20
Luján (2021042501165322700_b21-0080057) 2001; 12
Clark (2021042501165322700_b7-0080057) 1997; 38
Gerfen (2021042501165322700_b14-0080057) 2004
Fuxe (2021042501165322700_b13-0080057) 2010; 16
Pinna (2021042501165322700_b26-0080057) 2014; 253
Zwier (2021042501165322700_b36-0080057) 2010; 15
Canals (2021042501165322700_b4-0080057) 2003; 278
Ciruela (2021042501165322700_b6-0080057) 2010; 28
Trifilieff (2021042501165322700_b32-0080057) 2011; 51
Ledent (2021042501165322700_b19-0080057) 1997; 388
Bonaventura (2021042501165322700_b2-0080057) 2014; 79
Fuxe (2021042501165322700_b12-0080057) 1998; 26
Ramlackhansingh (2021042501165322700_b27-0080057) 2011; 76
Vallano (2021042501165322700_b33-0080057) 2011; 10
Cabello (2021042501165322700_b3-0080057) 2009; 109
Ferré (2021042501165322700_b11-0080057) 2004; 10
Müller (2021042501165322700_b23-0080057) 2011
Xu (2021042501165322700_b35-0080057) 2005; 105
Cottet (2021042501165322700_b8-0080057) 2013; 41
Kamiya (2021042501165322700_b17-0080057) 2003; 306
Levey (2021042501165322700_b20-0080057) 1993; 90
Varani (2021042501165322700_b34-0080057) 2010; 24
Torvinen (2021042501165322700_b31-0080057) 2002; 113
Hodgson (2021042501165322700_b16-0080057) 2009; 330
Paxinos (2021042501165322700_b24-0080057) 2007
Ciruela (2021042501165322700_b5-0080057) 2004; 76
Maurel (2021042501165322700_b22-0080057) 2008; 5
Tanganelli (2021042501165322700_b30-0080057) 2004; 10
Rosin (2021042501165322700_b28-0080057) 2003; 61
Albizu (2021042501165322700_b1-0080057) 2010; 6
Fernández-Dueñas (2021042501165322700_b9-0080057) 2012; 123
References_xml – volume: 26
  start-page: 258
  year: 1998
  ident: 2021042501165322700_b12-0080057
  article-title: Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia
  publication-title: Brain Res. Brain Res. Rev.
  doi: 10.1016/S0165-0173(97)00049-0
  contributor:
    fullname: Fuxe
– volume: 61
  start-page: S12
  issue: Suppl. 6
  year: 2003
  ident: 2021042501165322700_b28-0080057
  article-title: Anatomy of adenosine A2A receptors in brain: morphological substrates for integration of striatal function
  publication-title: Neurology
  doi: 10.1212/01.WNL.0000095205.33940.99
  contributor:
    fullname: Rosin
– volume: 24
  start-page: 587
  year: 2010
  ident: 2021042501165322700_b34-0080057
  article-title: A2A adenosine receptor overexpression and functionality, as well as TNF-alpha levels, correlate with motor symptoms in Parkinson’s disease
  publication-title: FASEB J.
  doi: 10.1096/fj.09-141044
  contributor:
    fullname: Varani
– volume: 388
  start-page: 674
  year: 1997
  ident: 2021042501165322700_b19-0080057
  article-title: Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor
  publication-title: Nature
  doi: 10.1038/41771
  contributor:
    fullname: Ledent
– volume: 38
  start-page: 41
  year: 1997
  ident: 2021042501165322700_b7-0080057
  article-title: Special Report: The 1996 Guide for the Care and Use of Laboratory Animals
  publication-title: ILAR J.
  doi: 10.1093/ilar.38.1.41
  contributor:
    fullname: Clark
– volume: 10
  start-page: 659
  year: 2011
  ident: 2021042501165322700_b33-0080057
  article-title: An update on adenosine A2A receptors as drug target in Parkinson’s disease
  publication-title: CNS Neurol. Disord. Drug Targets
  doi: 10.2174/187152711797247803
  contributor:
    fullname: Vallano
– volume: 41
  start-page: 148
  year: 2013
  ident: 2021042501165322700_b8-0080057
  article-title: Fluorescent ligands to investigate GPCR binding properties and oligomerization
  publication-title: Biochem. Soc. Trans.
  doi: 10.1042/BST20120237
  contributor:
    fullname: Cottet
– volume: 18
  start-page: 1619
  year: 2009
  ident: 2021042501165322700_b25-0080057
  article-title: Novel investigational adenosine A2A receptor antagonists for Parkinson’s disease
  publication-title: Expert Opin. Investig. Drugs
  doi: 10.1517/13543780903241615
  contributor:
    fullname: Pinna
– volume: 278
  start-page: 46741
  year: 2003
  ident: 2021042501165322700_b4-0080057
  article-title: Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M306451200
  contributor:
    fullname: Canals
– volume: 76
  start-page: 5354
  year: 2004
  ident: 2021042501165322700_b5-0080057
  article-title: Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors
  publication-title: Anal. Chem.
  doi: 10.1021/ac049295f
  contributor:
    fullname: Ciruela
– volume: 6
  start-page: 587
  year: 2010
  ident: 2021042501165322700_b1-0080057
  article-title: Time-resolved FRET between GPCR ligands reveals oligomers in native tissues
  publication-title: Nat. Chem. Biol.
  doi: 10.1038/nchembio.396
  contributor:
    fullname: Albizu
– volume: 28
  start-page: 407
  year: 2010
  ident: 2021042501165322700_b6-0080057
  article-title: Lighting up multiprotein complexes: lessons from GPCR oligomerization
  publication-title: Trends Biotechnol.
  doi: 10.1016/j.tibtech.2010.05.002
  contributor:
    fullname: Ciruela
– volume: 90
  start-page: 8861
  year: 1993
  ident: 2021042501165322700_b20-0080057
  article-title: Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.90.19.8861
  contributor:
    fullname: Levey
– volume: 50
  start-page: 275
  year: 1996
  ident: 2021042501165322700_b29-0080057
  article-title: The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments
  publication-title: Prog. Neurobiol.
  doi: 10.1016/S0301-0082(96)00040-8
  contributor:
    fullname: Schwarting
– volume: 16
  start-page: e18
  year: 2010
  ident: 2021042501165322700_b13-0080057
  article-title: Adenosinedopamine interactions in the pathophysiology and treatment of CNS disorders
  publication-title: CNS Neurosci. Ther.
  doi: 10.1111/j.1755-5949.2009.00126.x
  contributor:
    fullname: Fuxe
– volume: 12
  start-page: 1285
  year: 2001
  ident: 2021042501165322700_b21-0080057
  article-title: Immunocytochemical localization of metabotropic glutamate receptor type 1 alpha and tubulin in rat brain
  publication-title: Neuroreport
  doi: 10.1097/00001756-200105080-00046
  contributor:
    fullname: Luján
– volume: 10
  start-page: 265
  year: 2004
  ident: 2021042501165322700_b11-0080057
  article-title: Adenosine A2A-dopamine D2 receptor-receptor heteromers. Targets for neuro-psychiatric disorders
  publication-title: Parkinsonism Relat. Disord.
  doi: 10.1016/j.parkreldis.2004.02.014
  contributor:
    fullname: Ferré
– volume: 250
  start-page: 1429
  year: 1990
  ident: 2021042501165322700_b15-0080057
  article-title: D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons
  publication-title: Science
  doi: 10.1126/science.2147780
  contributor:
    fullname: Gerfen
– volume: 73
  start-page: 317
  year: 2012
  ident: 2021042501165322700_b18-0080057
  article-title: Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism
  publication-title: Neuron
  doi: 10.1016/j.neuron.2011.10.038
  contributor:
    fullname: Kern
– volume: 10
  start-page: 273
  year: 2004
  ident: 2021042501165322700_b30-0080057
  article-title: Striatal plasticity at the network level. Focus on adenosine A2A and D2 interactions in models of Parkinson’s disease
  publication-title: Parkinsonism Relat. Disord.
  doi: 10.1016/j.parkreldis.2004.02.015
  contributor:
    fullname: Tanganelli
– volume: 330
  start-page: 294
  year: 2009
  ident: 2021042501165322700_b16-0080057
  article-title: Characterization of the potent and highly selective A2A receptor antagonists preladenant and SCH 412348 [7-[2-[4-2,4-difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in rodent models of movement disorders and depression
  publication-title: J. Pharmacol. Exp. Ther.
  doi: 10.1124/jpet.108.149617
  contributor:
    fullname: Hodgson
– start-page: 1290
  year: 2011
  ident: 2021042501165322700_b23-0080057
  article-title: Recent developments in adenosine receptor ligands and their potential as novel drugs
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbamem.2010.12.017
  contributor:
    fullname: Müller
– volume: 20
  start-page: 482
  year: 1997
  ident: 2021042501165322700_b10-0080057
  article-title: Adenosinedopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia
  publication-title: Trends Neurosci.
  doi: 10.1016/S0166-2236(97)01096-5
  contributor:
    fullname: Ferré
– volume: 113
  start-page: 709
  year: 2002
  ident: 2021042501165322700_b31-0080057
  article-title: Interactions among adenosine deaminase, adenosine A(1) receptors and dopamine D(1) receptors in stably cotransfected fibroblast cells and neurons
  publication-title: Neuroscience
  doi: 10.1016/S0306-4522(02)00058-1
  contributor:
    fullname: Torvinen
– volume: 5
  start-page: 561
  year: 2008
  ident: 2021042501165322700_b22-0080057
  article-title: Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.1213
  contributor:
    fullname: Maurel
– volume: 79
  start-page: 90
  year: 2014
  ident: 2021042501165322700_b2-0080057
  article-title: L-DOPA-treatment in primates disrupts the expression of A(2A) adenosine-CB(1) cannabinoid-D(2) dopamine receptor heteromers in the caudate nucleus
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2013.10.036
  contributor:
    fullname: Bonaventura
– volume: 76
  start-page: 1811
  year: 2011
  ident: 2021042501165322700_b27-0080057
  article-title: Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease
  publication-title: Neurology
  doi: 10.1212/WNL.0b013e31821ccce4
  contributor:
    fullname: Ramlackhansingh
– volume: 51
  start-page: 111
  year: 2011
  ident: 2021042501165322700_b32-0080057
  article-title: Detection of antigen interactions ex vivo by proximity ligation assay: endogenous dopamine D2-adenosine A2A receptor complexes in the striatum
  publication-title: Biotechniques
  doi: 10.2144/000113719
  contributor:
    fullname: Trifilieff
– volume: 105
  start-page: 267
  year: 2005
  ident: 2021042501165322700_b35-0080057
  article-title: Therapeutic potential of adenosine A(2A) receptor antagonists in Parkinson’s disease
  publication-title: Pharmacol. Ther.
  doi: 10.1016/j.pharmthera.2004.10.007
  contributor:
    fullname: Xu
– volume: 15
  start-page: 1248
  year: 2010
  ident: 2021042501165322700_b36-0080057
  article-title: A fluorescent ligand-binding alternative using Tag-lite® technology
  publication-title: J. Biomol. Screen.
  doi: 10.1177/1087057110384611
  contributor:
    fullname: Zwier
– start-page: 445
  volume-title: The Rat Nervous System
  year: 2004
  ident: 2021042501165322700_b14-0080057
  article-title: Basal ganglia
  doi: 10.1016/B978-012547638-6/50019-5
  contributor:
    fullname: Gerfen
– volume: 306
  start-page: 544
  year: 2003
  ident: 2021042501165322700_b17-0080057
  article-title: Oligomerization of adenosine A2A and dopamine D2 receptors in living cells
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/S0006-291X(03)00991-4
  contributor:
    fullname: Kamiya
– volume: 109
  start-page: 1497
  year: 2009
  ident: 2021042501165322700_b3-0080057
  article-title: Metabotropic glutamate type 5, dopamine D2 and adenosine A2a receptors form higher-order oligomers in living cells
  publication-title: J. Neurochem.
  doi: 10.1111/j.1471-4159.2009.06078.x
  contributor:
    fullname: Cabello
– volume: 123
  start-page: 373
  year: 2012
  ident: 2021042501165322700_b9-0080057
  article-title: Molecular determinants of A2AR-D2R allosterism: role of the intracellular loop 3 of the D2R
  publication-title: J. Neurochem.
  doi: 10.1111/j.1471-4159.2012.07956.x
  contributor:
    fullname: Fernández-Dueñas
– start-page: 547
  volume-title: The Rat Brain in Stereotaxic Coordinates
  year: 2007
  ident: 2021042501165322700_b24-0080057
  contributor:
    fullname: Paxinos
– volume: 253
  start-page: 180
  year: 2014
  ident: 2021042501165322700_b26-0080057
  article-title: L-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: biochemical and behavioral studies
  publication-title: Exp. Neurol.
  doi: 10.1016/j.expneurol.2013.12.021
  contributor:
    fullname: Pinna
SSID ssj0062839
Score 2.0329213
Snippet Abstract Parkinson’s disease (PD) is a dopaminergic-related pathology in which basal ganglia functioning are altered. It has been postulated that a direct...
SourceID crossref
SourceType Aggregation Database
Title Untangling dopamine-adenosine receptor assembly in experimental parkinsonism
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfGJhAviA0QH2OKBG_IZY6dOnnc1qF9MF5Y0d4qx75NSEtatekD_PXc2U4T6B7GXqLWtZ3Kdzr_fHe_M2MfbQrWUFrFvrCWq8xlPJfScpOJ3OCByEJJbOSLb8OTsTq7yq66XFXPLmnKgf19J6_kIVLFNpQrsWT_Q7KrSbEBP6N88YkSxue9ZDyuEdrdeEK5w8NvhYiRG0flvwk7oi2DWUNJkosFVOWtZ_j9VdF_ZshTjoi7rSMYUeooRG3CNTkLrx0VEEUY-3V8EZjXPswuyA3NR0ugb4ciMMR--J9GNhQzjs6B5Txm5qJB_HQ2WMU_pk0DLXOoLQVOOUF-Qlnh7N-nkbGIPdC03fadFUL1nBXBvupMcTxTBpsG_bZgc9csOkIIFIOrqgGVFlOy27faWP0_29kqyZCONzh6gmMnYewjtpWiPfLR_NPzdsMeIsIqPG82_rdYxRbHfu7e28MtPQBy-Zw9iyeH5CCowTbbgHqHPQ53if7aYU8uYpbEC_a104tkXS-SVi-SVi-Sn3XS14ukrxcv2fjL8eXRCY-3ZnArdC65A1dKk9oyNSovQVqrNQU_r50ApzUUuUTQWOTaCNh3iFeVESrTKe42uABoj1-xzXpaw2uWUEhODIvrAgqy7aaUCkAUhdOSqvwP37AP7ZpMZqE4ymR91d_eq9c79rRTmF222cyX8B7xXlPueWnteW_JH2xaVe8
link.rule.ids 315,783,787,867,27936,27937
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Untangling+dopamine-adenosine+receptor+assembly+in+experimental+parkinsonism&rft.jtitle=Disease+models+%26+mechanisms&rft.au=Fern%C3%A1ndez-Due%C3%B1as%2C+V%C3%ADctor&rft.au=Taura%2C+Jaume+J.&rft.au=Cottet%2C+Martin&rft.au=G%C3%B3mez-Soler%2C+Maricel&rft.date=2014-01-01&rft.issn=1754-8403&rft.eissn=1754-8411&rft_id=info:doi/10.1242%2Fdmm.018143&rft.externalDBID=n%2Fa&rft.externalDocID=10_1242_dmm_018143
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1754-8403&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1754-8403&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1754-8403&client=summon